🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT02751060
Enrolling by invitation Observational

Evaluation of Plasma Non-coding RNAs as Biomarkers in Coronary Heart Disease

NCT02751060 · tracked via the Priya Life Science China tracker
Sponsor
Tongji Hospital
Phase
Observational
Started
2016-04
Last updated
2024-04-10

Condition(s) studied

Coronary Disease

Investigational drug(s) / intervention(s)

No intervention

Study summary

The purpose of this study is to determine whether the expression level of miR-320a are effective as biomarker in evaluating the diagnosis, prognosis and treatment effects of coronary heart disease.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: 1. 18 years of age or older; 2. the most recent symptoms of coronary heart disease within 7 days; 3. meet one of the following conditions: A. clinical history of typical ischemic chest pain (more than 5 minutes of persistent chest pain); B. serum cardiac biomarkers positive (TnT/I or creatine kinase peak greater than 99% of URL); C. Electrocardiogram changes of myocardial ischemia. Exclusion Criteria: 1. pregnant women or plan to; 2. participate in any drug clinical trials within 3 months; 3. patients with life-threatening complications, or the researchers determined that the survival time of patients with no more than 1 years; 4. serious neurological disease (Alzheimer's disease, Parkinson syndrome, progressive lower limbs or deaf patients); 5. previous history of cancer or tumor, or pathological examination confirmed precancerous lesions (such as breast ductal carcinoma in situ, or atypical hyperplasia of the cervix); 6. patients refused to comply with the requirements of this study to complete the research work; 7. according to the researchers, patients can not complete the study or not to comply with the requirements of this study (because of the reasons for the management or other reasons).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Tongji Hospital Wuhan Hubei

More Tongji Hospital trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT02751060 on ClinicalTrials.gov ↗ ← All trials in China